The first test for measuring T-Cell immunity against COVID-19 offered to the general public anywhere in the world.
The test measures the presence of T cells that recognize protein fragments from the SARS-CoV-2 virus, indicating (i) previous exposure to the SARS-CoV-2 virus or (ii) an immune response induced by a COVID-19 vaccine.
Provider of ELISpot Confirm kit: SARS-CoV-2, a CE-marked test kit for assessing T-cell reactivity against COVID-19 that has been used in academic research and most major vaccine development projects.
Legehuset is ABC's partner for blood sampling and care provision and one of Swedens largest providers of COVID-19 testing.
A dedicated sampling site was setup at Norrsken House (Birger Jarlsgatan 57 C) for the initial launch (until March 25). Additional sites will be created with selected healthcare providers across Sweden.